Impact of thyroid cancer still on the rise in Australia

Embargoed until: Publicly released: 2022-03-11 03:00

Australia; International

Photo by National Cancer Institute on Unsplash

Mortality and disability as a result of thyroid cancer is still rising in Australia despite declines across the European Union, according to international researchers. The team tracked thyroid cancer rates, mortality rates and the amount of years affected by thyroid cancer-related disability across 16 European countries along with US, Australia and Canada from 1990 to 2019. The researchers say while 13 of the 19 countries saw an increase in the overall rate of thyroid cancer, Australia, the US and Denmark were the only countries that have seen mortality and disability-affected years increase across that time. In Australia, they say the annual increase in mortality was 0.6 per cent.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page The URL will go live after the embargo ends

Journal/
conference: JAMA Otolaryngology–Head & Neck Surgery

Research:Paper

Organisation/s: St George’s University Hospitals NHS Foundation Trust, UK

Funder: Dr Shalhoub reported receiving grants from the National Institute for Health Research and BHF, and consulting fees from Oxford Healthtech Ltd outside the submitted work. No other disclosureswere reported.

Media Contact/s

Contact details are only visible to registered journalists.